Financial statements Inventiva Biomedical And Research

Balance sheet of Inventiva Biomedical And Research

Company age:
Age:
23 y. 11 m. 12 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of INVENTIVA BIOMEDICAL AND RESEARCH

Year
2018
2019
2020
2021
2022
2023
Total assets 6 237 369,28 7 838 173,18 8 802 679,68 9 152 967,98 10 951 905,90 12 405 951,22
A. Fixed assets 1 269 955,38 1 213 674,47 1 171 322,70 1 564 308,09 1 414 633,80 1 265 293,80
B. Current assets 4 967 413,90 6 624 498,71 7 631 356,98 7 588 659,89 9 537 272,10 11 140 657,42
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 6 237 369,28 7 838 173,18 8 802 679,68 9 152 967,98 10 951 905,90 12 405 951,22
A. Equity 5 912 654,78 7 646 617,07 8 592 072,79 8 926 675,05 10 728 514,60 12 131 937,57
B. Liabilities and provisions for liabilities 324 714,50 191 556,11 210 606,89 226 292,93 223 391,30 274 013,65
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 288 949,96 160 872,97 184 654,15 205 070,59 277 112,54 262 489,66
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.